Taylor A.Goodspeed


San Francisco + 1.415.875.5804

Taylor Goodspeed focuses on regulatory, compliance, and civil litigation matters involving the health care industry. She counsels and defends hospitals, health systems, and other health care entities in civil fraud and abuse investigations and litigation, particularly under the civil False Claims Act (FCA) and similar state laws. She also routinely provides strategic counsel and health care regulatory advice to direct-to-consumer telemedicine and technology companies.

Taylor helps steer clients through high-profile investigations from federal and state agencies. She has also counseled health systems and emerging companies on federal and state anti-kickback statutes, federal and state referral prohibitions, licensure requirements, and state corporate practice of medicine provisions.

Prior to joining Jones Day, Taylor coauthored multiple publications on public attitudes towards noninvasive prenatal testing, such as cell-free fetal DNA technology.

Taylor maintains an active pro bono practice, serving on Jones Day's Anti-Human Trafficking Committee and on the American Hospital Association's (AHA) Human Trafficking Advisory Committee.

Taylor will be serving on the Women's Leadership Council for the American Health Law Association (AHLA) for a two-year term. She is also a member of the California Society for Healthcare Attorneys.


  • Academic medical center considers multi-state second opinion servicesJones Day provided strategic health regulatory guidance to a preeminent academic medical center in connection with their multi-state second opinion and telehealth programs.
  • Innovative primary care clinic expands platform and offeringsJones Day is providing on-going strategic regulatory guidance and advice to a membership-based primary care practice in connection with telemedicine, COVID-19 response, and general health care regulatory and compliance matters.
  • Digital health company expands telehealth programming in response to the COVID-19 public health crisisJones Day represented a digital health company in the expansion of their telehealth programming in response to the COVID-19 public health crisis.
  • Emerging specialty service launches telehealth platformJones Day advised an emerging direct to consumer telehealth organization focusing on teledermatology with terms of service, privacy policy, and telehealth consent for launching operations in several states across the U.S.
  • National digital health company launches government partnershipJones Day advised a large digital health company with multi-clinical services in negotiating a partnership with a state government program to provide telehealth and telemedicine consults during the COVID-19 state of emergency.
  • Durable medical equipment company defends against False Claims Act qui tam lawsuitJones Day is representing a durable medical equipment company in connection with a False Claims Act investigation alleging violation of state best price requirements.
  • Hospital system defends against novel federal and state False Claims Act qui tam lawsuitsJones Day is representing a hospital system in connection with two novel federal and state False Claims Act matters alleging improper arrangements with Medicaid managed health care plans.
  • Large digital health company grows operations across U.S.Jones Day advised a large digital health company in expanding operations throughout multiple states in the U.S. and in responding to several state regulator inquiries regarding its operations.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.